Teds Topical Pain Cream
NDC 58133-210
Product Information
Teds Topical Pain Cream is a OTC MONOGRAPH NOT FINAL-approved product labeled by Cosmetic Specialty Labs, Inc.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a product. This product entry covers the primary NDC 58133-210 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 58133-210?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- METHYL SALICYLATE (UNII: LAV5U5022Y)
- SALICYLIC ACID (UNII: O414PZ4LPZ) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- DIMETHYL SULFONE (UNII: 9H4PO4Z4FT)
- ARNICA MONTANA FLOWER (UNII: OZ0E5Y15PZ)
- CETYL ALCOHOL (UNII: 936JST6JCN)
- WATER (UNII: 059QF0KO0R)
- RESVERATROL (UNII: Q369O8926L)
- SODIUM LAURYL GLYCOL CARBOXYLATE (UNII: 8L0472VMYL)
- SODIUM HYDROXYPROPYLSULFONATE LAURYLGLUCOSIDE-7 CROSSPOLYMER (UNII: K9R4VJQ1IB)
- SORBITAN OLIVATE (UNII: MDL271E3GR)
- STEARIC ACID (UNII: 4ELV7Z65AP)
- BOSWELLIA SERRATA RESIN OIL (UNII: 5T1XCE6K8K)
- CETEARYL OLIVATE (UNII: 58B69Q84JO)
- ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)
- GLYCERIN (UNII: PDC6A3C0OX)
- GLYCERYL STEARATE SE (UNII: FCZ5MH785I)
- PEG-100 STEARATE (UNII: YD01N1999R)
- PHENOXYETHANOL (UNII: HIE492ZZ3T)
- POLYSORBATE 20 (UNII: 7T1F30V5YH)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 311635 - methyl salicylate 10 % Topical Cream
- RxCUI: 311635 - methyl salicylate 100 MG/ML Topical Cream
* Please review the full disclaimer at the bottom of this page.